RESTYLANE® CONTOUR is an advanced hyaluronic acid (HA) dermal filler formulated to build volume in the midface and cheeks. This FDA-approved injectable is the newest addition to the RESTYLANE® family of XpresHAn Technology™ fillers and is a favorite at Deep Blue Med Spa for its ability to create natural-looking contour.
RESTYLANE® CONTOUR is ideal for individuals looking to:
- Build volume in the cheeks
- Sculpt the cheekbones
- Correct midface asymmetry
Each RESTYLANE® CONTOUR treatment takes approximately 30 minutes, depending on the patient’s cosmetic goals. In addition to our experts applying a topical numbing agent, RESTYLANE® CONTOUR contains lidocaine, making it more comfortable to inject. Patients typically see results immediately following injections. However, final results are typically visible 2-3 days after their appointment. Mild swelling is both common and normal. Results can last up to 48 weeks.
We recommend annual or bi-annual follow-up sessions to maintain RESTYLANE® CONTOUR results and achieve long-lasting aesthetic enhancement in the cheeks and midface.
How does RESTYLANE® CONTOUR work?
- Non-surgical treatment
- Builds natural-looking volume in the midface and cheeks
- Sculpts beautiful and youthful cheekbones
Is RESTYLANE® CONTOUR Right For Me?
- Don’t want downtime or surgery?
- Seeking a non-surgical alternative to sculpt the midface and cheeks?
- Looking to add contour to your face shape?
- Want to build volume in the midface?
What Do I Need To Know About RESTYLANE® CONTOUR?
Consultations for RESTYLANE® CONTOUR are available at all Deep Blue Med Spa locations.
An injectable appointment generally takes 30 minutes.
Results are visible immediately.
No downtime required.
Patients can expect to have mild bruising, swelling, and redness at or around the treatment site.
Follow-up treatments are recommended to maintain results.
Results can last up to one year.
Schedule Your RESTYLANE® CONTOUR Appointment
View All Specials >
The Medical Professionals at Deep Blue Med Spa have either authored or reviewed and approved this content.